Product Pathways
BCP0039 Capecitabine(Xeloda)
Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
BCP0094 Pemetrexed disodium
Pemetrexed disodium (Alimta) is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respectively.
BCP0355 Fludarabine(Fludara)
Fludarabine (Fludara, F-ara-A, NSC 118218) is a STAT1 activation inhibitor and a DNA synthesis inhibitor.
BCP0393 Adrucil(Fluorouracil)
Adrucil(Fluorouracil) belongs to the family of drugs called antimetabolites.
BCP0404 Arranon
Nelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia.
BCP0417 Bendamustine Hydrochloride
Bendamustine is a nitrogen mustard used in the treatment of chronic lymphocytic leukemias (CLL) and lymphomas.
BCP0424 Bleomycin sulfate
Bleomycin, known as an chemotherapy agent, is a glycopeptide antibiotic produced by the bacterium Streptomyces verticillus.
BCP000438 Clafen(Cyclophosphamide)
This agent inhibited cell proliferation of NCI-H727 with IC50 at 9.3 nM.
BCP0470 apaziquone
An indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.
BCP0480 Carmustine(BiCNU)
Carmustine(BiCNU) is a cell-cycle phase nonspecific alkylating antineoplastic agent with ED50 ranging from 5.0 礛 to 11.9 礛.
第一页 1 2 3 4 5 6 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.